Transplantation News

Researchers are calling for the creation of a comprehensive framework to address current barriers to xenotransplantation in clinical practice, including issues of rejection, infection, legal regulations, informed consent and animal rights.

Physicians consider factors beyond kidney donor profile index, such as cold ischemia time, when deciding to accept a marginal kidney, according to a presentation at the American Transplant Congress.

An assessment of the 25-year risk of end-stage kidney disease among living kidney donors revealed different risks for different groups of donors, according to data presented at the American Transplant Congress.

Between 2019 and 2021, organ offers and workload over time for liver and kidney allocation increased significantly, according to findings presented at the American Transplant Congress.

In this video, Philippe Gauthier, MD, a transplant nephrologist and senior medical director of organ health at Natera, discusses a two-threshold algorithm that uses donor-derived cell-free DNA and quantity to detect transplant rejection.

An updated MELD 3.0 amends existing sex-based disparities in access to liver transplantation among women, according to a presenter at the American Transplant Congress 2022.

The Organ Procurement and Transplantation Network identified a 5.1% increase in transplants per 100 active patient years following its 2021 policy change, according to a presentation at the American Transplant Congress.

The eGFR equation that includes creatinine and cystatin C but not the race coefficient may be preferable to the eGFR equation that only includes creatinine for measuring racial differences in the risk of kidney failure.

Transplanting kidneys from donors who have the hepatitis C virus into patients who are HCV-negative is not associated with increased risk for early graft failure, according to a presentation at the American Transplant Congress.

Although the development and use of biomarkers in liver transplantation has progressed in recent years, challenges and limitations remain, according to presenters at the American Transplant Congress 2022.